Valeant Pharmaceuticals International, Vital Science deal

Valeant will purchase OTC dermatology company Vital for C$10.5 million ($10.3 million). Valeant said Vital has annualized sales of about C$11 million ($10.8 million). Valeant said the move is part of ...